NIH budget cuts are threatening key medical research programs, shrinking training grants, and leaving young researchers ...

Senhwa Biosciences begins patient dosing in NCI-sponsored pilot study of Pidnarulex pharmacodynamics in patients with advanced solid tumours: Taipei, Taiwan Thursday, July 17, 202 ...

For decades, international researchers have received a small slice of the National Institutes of Health budget. In 2024, out ...

Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that its new drug ...

We are interested in proposals aligned with the collaborative's overall goals, including understanding health challenges and overcoming barriers to recruitment into clinical research, integration of ...

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...

Today, genomics is saving countless lives and even entire species, thanks in large part to a commitment to collaborative and ...

Dr. Lotan graduated with high honors from the University of Texas at Austin and with honors from Baylor College of Medicine in Houston. He trained in general surgery and urology at UT Southwestern ...

The Urology Care Foundation, the world's leading nonprofit urological health foundation and the official foundation of the ...

A study led by Megan Curtis, MD, an assistant professor in the Division of Infectious Diseases at WashU Medicine (right), and ...